Lupin receives tentative U.S. FDA approval for Siponimod Tablets
Approval covers 0.25 mg, 1 mg and 2 mg strengths for multiple sclerosis treatment
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Medley launches Biscal D –Calcium and Vitamin D3 fortified biscuit
Medley expands nutraceutical portfolio with fortified biscuit offering
Lupin signs exclusive licensing agreement with Valorum Biologics for Armlupeg in the U.S.
Companies outline roles in manufacturing, commercialisation and distribution
Granules India reports completion of FDA inspection with zero observations
Granules India outlines the inspection outcome and operational role of its U.S. subsidiary
Urgent reforms to ensure safe medicines: Need of the hour
Dr Suresh Saravdekar, former Assistant Director, Ministry of Medical Education and Health, State of Maharashtra, and Honorary…
India pharma and healthcare funding reaches $38.6 million in November 2025
Early-stage deals account for majority of investment activity
Corona Remedies announces IPO opening on 8 December 2025
Price band set at ₹1,008–₹1,062 per equity share
Cipla launches Ciplostem cell therapy for Knee Osteoarthritis in India
DCGI approval marks Cipla’s entry into orthobiologic medicine
Merck announces winners of the Merck Young Scientist Award 2025
Fourth edition recognises researchers across chemical and biological sciences categories
Green Pharma: How the industry can reduce its carbon footprint without compromising growth
Dr Supriya Shidhaye outlines how the pharma industry can shrink emissions while maintaining output and market expansion